These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12924053

  • 1. [Adverse effects of concomitant chemoradiotherapy and their prevention and treatment].
    Horová H, Soumarová R, Seneklová Z, Růzicková J.
    Cas Lek Cesk; 2003; 142 Suppl 1():53-6. PubMed ID: 12924053
    [Abstract] [Full Text] [Related]

  • 2. [Pulmonary toxicity of antimitotic agent-radiotherapy combination].
    Cosset JM, Chirat E, Carde P, Moisson P, Girinski T, Tchernia G.
    Therapie; 1986; 41(4):293-6. PubMed ID: 2437667
    [No Abstract] [Full Text] [Related]

  • 3. Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives.
    Seegenschmiedt MH.
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():25-9. PubMed ID: 9830452
    [Abstract] [Full Text] [Related]

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 5. [Overview of concomitant chemoradiotherapy of solid tumors].
    Slampa P.
    Cas Lek Cesk; 2003 Mar 15; 142 Suppl 1():4-8. PubMed ID: 12924041
    [Abstract] [Full Text] [Related]

  • 6. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
    Tejwani A, Wu S, Jia Y, Agulnik M, Millender L, Lacouture ME.
    Cancer; 2009 Mar 15; 115(6):1286-99. PubMed ID: 19170238
    [Abstract] [Full Text] [Related]

  • 7. [Proton beam therapy combined with chemotherapy for advanced cancer].
    Fuwa N.
    Gan To Kagaku Ryoho; 2011 Sep 15; 38(9):1385-9. PubMed ID: 21918332
    [Abstract] [Full Text] [Related]

  • 8. [Concomitant chemoradiotherapy in the treatment of vulvar carcinoma].
    Soumarová R, Kalábová R, Perková H.
    Cas Lek Cesk; 2003 Sep 15; 142 Suppl 1():51-2. PubMed ID: 12924052
    [Abstract] [Full Text] [Related]

  • 9. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C, Epstein J, Sonis S.
    Head Neck; 2003 Dec 15; 25(12):1057-70. PubMed ID: 14648865
    [Abstract] [Full Text] [Related]

  • 10. [Chemoradiotherapy].
    Mazeron JJ.
    Bull Cancer; 2005 Dec 15; 92(12):1025-6. PubMed ID: 16396747
    [No Abstract] [Full Text] [Related]

  • 11. [Evidence based of chemoradiotherapy in cervix carcinoma].
    Joly-Lobbedez F.
    Cancer Radiother; 2009 Oct 15; 13(6-7):503-6. PubMed ID: 19695934
    [Abstract] [Full Text] [Related]

  • 12. New strategies for management of oral mucositis in cancer patients.
    Peterson DE.
    J Support Oncol; 2006 Feb 15; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [Abstract] [Full Text] [Related]

  • 13. Neurotoxicity of the CNS: diagnosis, treatment and prevention.
    Ricard D, Soussain C, Psimaras D.
    Rev Neurol (Paris); 2011 Oct 15; 167(10):737-45. PubMed ID: 21899866
    [Abstract] [Full Text] [Related]

  • 14. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.
    Arch Otolaryngol Head Neck Surg; 2004 Jul 15; 130(7):861-7. PubMed ID: 15262764
    [Abstract] [Full Text] [Related]

  • 15. [Biological basis for concomitant chemoradiotherapy in carcinomas].
    Favaudon V, Noël G.
    Bull Cancer; 2005 Dec 15; 92(12):1027-31. PubMed ID: 16396748
    [Abstract] [Full Text] [Related]

  • 16. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study.
    Puts MT, Monette J, Girre V, Pepe C, Monette M, Assouline S, Panasci L, Basik M, Miller WH, Batist G, Wolfson C, Bergman H.
    Crit Rev Oncol Hematol; 2011 May 15; 78(2):138-49. PubMed ID: 20444620
    [Abstract] [Full Text] [Related]

  • 17. [Concomitant radiochemotherapy in solid tumors].
    Slampa P, Soumarová R, Coupek P, Tichá H.
    Vnitr Lek; 2001 Jul 15; 47(7):470-7. PubMed ID: 11505719
    [Abstract] [Full Text] [Related]

  • 18. Combining systemic therapies with radiation in breast cancer.
    Adamowicz K, Marczewska M, Jassem J.
    Cancer Treat Rev; 2009 Aug 15; 35(5):409-16. PubMed ID: 19464806
    [Abstract] [Full Text] [Related]

  • 19. Chemoradiotherapy in gastrointestinal malignancies.
    Willett CG, Czito BG.
    Clin Oncol (R Coll Radiol); 2009 Sep 15; 21(7):543-56. PubMed ID: 19577442
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of early and late toxicities in chemoradiation trials.
    Bentzen SM, Trotti A.
    J Clin Oncol; 2007 Sep 10; 25(26):4096-103. PubMed ID: 17827459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.